Non-melanoma skin cancer in patients with atopic dermatitis treated with topical tacrolimus.

Objective: To determine whether atopic dermatitis (AD) patients treated with tacrolimus ointment experienced an increased risk of non-melanoma skin cancer (NMSC).

Methods: Data were collected from 9813 adult and paediatric patients with AD who applied 0.03% or 0.